GLP-1 medications arent a foreign substance like a pharmaceutical created by mixing chemicals in a lab
Cellular senescence as a mechanism and target in chronic lung diseases
While these medications share the same active ingredient, they are approved for different uses and are prescribed at different dosages
The side-effects of GLP-1s are predominantly gastrointestinal, including nausea, vomiting, heartburn, and gastroparesis (stomach slowing or paralysis) all symptoms which cause acid reflux
Insurers are basing their coverage decisions, in part, on rebates, discounts that are offered by drugmakers as a negotiating chip to persuade insurers to cover one product over a competitor
The existing amylin analogue pramlintide (sold as Symlin in the US for diabetes management) requires multiple daily injections